Shmuel Cabilly

О себе

Shmuel Cabilly is an Israeli immunologist, inventor, and angel investor best known for the recombinant-antibody "Cabilly" patents developed during his City of Hope/Genentech work. He has served on the boards of multiple life-science companies, including RedHill Biopharma, and has been publicly identified as an investor in Israeli healthtech and biotech companies such as Treato, Raziel Therapeutics, and DiA Imaging Analysis. His profile fits both a capital owner and a biotech ecosystem influencer, but not a formal fund operator.

Области интересов